Today, the European Commission has proposed an update of the legal base of the European Institute of Innovation and Technology (EIT) as well as its new Strategic Innovation Agenda for 2021-2027.
The EIT is an independent EU body created in 2008 that is strengthening Europe’s ability to innovate. The proposals adopted today will align the EIT with the EU’s next research and innovation programme Horizon Europe (2021-2027) delivering on the Commission’s commitment to further boost Europe’s innovation potential. With a proposed budget of €3 billion, which represents an increase of €600 million or 25% compared to the current Strategic Innovation Agenda (2014-2020), the EIT will fund activities of existing and new Knowledge and Innovation Communities (KICs) and support the innovation capacity of 750 higher education institutions.
Tibor Navracsics, Commissioner for Education, Culture, Youth and Sport, responsible for the EIT, said: “Since 2008, the European Institute of Innovation and Technology has been nurturing talent and creativity through a unique focus on education and entrepreneurship. The strategy we are now putting in place for 2021-2027 will help ensure that all of Europe’s regions benefit from the Institute’s potential and will further boost the innovation capacity of our higher education sector. And I am particularly proud to announce today the launch of a new Knowledge and Innovation Community to support innovation in the cultural and creative industries, planned for 2022.”
The EIT currently supports eight KICs which bring together companies, universities and research centres to form cross-border partnerships. The Strategic Innovation Agenda proposed for 2021-2027 is designed to achieve the following goals:
Increasing the regional impact of Knowledge and Innovation Communities: In the future, the EIT will strengthen its networks, involving more higher education institutions, businesses and research organisations by developing regional outreach strategies. The selection of cooperation partners and the preparation of KIC activities will be more inclusive. KICs will also develop links to Smart Specialisation Strategies, an EU initiative to spur economic growth and job creation by enabling each region to identify and develop its own competitive advantages.
Boosting the innovation capacity of higher education: The EIT will support 750 higher education institutions with funding, expertise and coaching, enabling them to develop economic activities within their area of interest. The Institute will design and launch activities particularly in countries with a lower innovation capacity. In doing so, the EIT will build on successful policy initiatives such as HEInnovate, a free self-assessment tool for all types of higher education institutions, or the Regional Innovation Impact Assessment Framework,which allows universities to assesshow they are fostering innovation in the regions they are based in.
Launch of new KICs: The EIT will launch two new KICs, selected in fields most relevant to Horizon Europe policy priorities. The first new KIC is set to focus on the cultural and creative industries and is planned to start in 2022. This sector has a high growth potential, many local grassroots initiatives and strong citizen appeal and is complementary to the existing eight KICs. The priority field of a second new KIC will be decided at a later stage; it is due to be launched in 2025.
The revised EIT Regulation ensures greater legal clarity and alignment with the EU Framework Programme for Research and Innovation. The new legal base also introduces a lean and simplified funding model for the EIT designed to more effectively encourage additional private and public investment. Finally, it reinforces the EIT’s governing structure.
Both therevised EIT Regulation and the Commission Decision on the Strategic Innovation Agenda for 2021-2027 will be presented to the European Parliament and the Council for discussion and adoption.
The European Institute of Innovation and Technology was established in 2008 by Regulation (EC) No 294/2008 amended by Regulation (EC) No 1292/2013and is based in Budapest. Its purpose is to address major societal challenges by improving the innovation capacity and performance of the EU through the integration of the knowledge triangle of education, research and innovation.
The EIT is a central part of the Commission proposal establishing Horizon Europe, the next EU research and innovation programme (2021-2027) with a proposed budget of €100 billion. The EIT is one of the three components of its “Innovative Europe” pillar. The Horizon Europe proposal sets out the funding for the EIT under the next long-term budget as well as its rationale, added value, areas of intervention and broad lines of activity. However, the Horizon Europe proposal itself does not provide the legal basis for continuing the EIT operations as from 2021. The legal base of the EIT remains the EIT Regulation that sets out its mission, its key tasks and the framework for its functioning.
With its proposed budget of €3 billion for 2021-2027 the Institute will boost innovation by supporting more than 10 000 graduates from its KICs’ Master and PhDs, around 600 new start-ups and more than 7000 existing ones.
The proposals presented today build on the external evaluation of the EIT carried out in 2017 which confirmed that the rationale behind the establishment of the EIT is valid.
Commission sets out key actions for a united front to beat COVID-19
Two days ahead of the meeting of European leaders on a coordinated response to the COVID-19 crisis, the Commission set out a number of actions needed to step up the fight against the pandemic. In a Communication adopted today, it calls on Member States to accelerate the roll-out of vaccination across the EU: by March 2021, at least 80% of people over the age of 80, and 80% of health and social care professionals in every Member State should be vaccinated. And by summer 2021, Member States should have vaccinated a minimum of 70% of the adult population.
The Commission also calls on Member States to continue to apply physical distancing, limit social contacts, fight disinformation, coordinate travel restrictions, ramp up testing, and increase contact tracing and genome sequencing to face up to the risk from new variants of the virus. As recent weeks have seen an upward trend in case numbers, more needs to be done to support healthcare systems and to address “COVID-fatigue” in the coming months, from accelerating vaccination across the board, helping our partners in the Western Balkans, the Southern and Eastern neighbourhood and in Africa.
Today’s Communication sets out key actions for Member States, the Commission, the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) which will help reduce risks and keep the virus under control:
Speeding up the roll-out of vaccination across the EU
By March 2021, at least 80% of people over the age of 80, and 80% of health and social care professionals in every Member State, should be vaccinated.
By summer 2021, Member States should have vaccinated 70% of the entire adult population.
The Commission, Member States and the EMA will work with companies to use the EU’s potential for increased vaccine manufacturing capacity to the fullest.
The Commission is working with Member States on vaccination certificates, in full compliance with EU data protection law, which can support the continuity of care. A common approach is to be agreed by the end of January 2021 to allow Member States’ certificates to be rapidly useable in health systems across the EU and beyond.
Testing and genome sequencing
Member States should update their testing strategies to account for new variants and expand the use of rapid antigen tests.
Member States should urgently increase genome sequencing to at least 5% and preferably 10% of positive test results. At present, many Member States are testing under 1% of samples, which is not enough to identify the progression of the variants or detect any new ones.
Preserving the Single Market and free movement while stepping up mitigation measures
Measures should be applied to further reduce the risk of transmission linked to the means of travel, such as hygiene and distancing measures in vehicles and terminuses.
All non-essential travel should be strongly discouraged until the epidemiological situation has considerably improved.
Proportionate travel restrictions, including testing of travellers, should be maintained for those travelling from areas with a higher incidence of variants of concern.
Ensuring European leadership and international solidarity
To ensure early access to vaccines, the Commission is to set up a Team Europe mechanism to structure the provision of vaccines shared by Member States with partner countries. This should allow for sharing with partner countries access to some of the 2.3 billion doses secured through the EU’s Vaccines Strategy, paying special attention to the Western Balkans, our Eastern and Southern neighbourhood and Africa.
The European Commission and Member States should continue supporting COVAX, including through early access to vaccines. Team Europe has already mobilised €853 million in support of COVAX, making the EU one of COVAX’s biggest donors.
Members of the College said:
President of the European Commission, Ursula von der Leyen, said: “Vaccination is essential to get out of this crisis. We have already secured enough vaccines for the entire population of the European Union. Now we need to accelerate the delivery and speed up vaccination. Our aim is to have 70% of our adult population vaccinated by summer. That could be a turning point in our fight against this virus. However, we will only end this pandemic when everyone in the world has access to vaccines. We will step up our efforts to help secure vaccines for our neighbours and partners worldwide.”
Vice-President Margaritis Schinas, responsible for Promoting our European Way of Life, said: “The emergence of new variants of the virus and substantial rises in cases leave us no room for complacency. Now more than ever must come a renewed determination for Europe to act together with unity, coordination and vigilance. Our proposals today aim to protect more lives and livelihoods later and relieve the burden on already stretched health care systems and workers. This is how the EU will come out of the crisis. The end of the pandemic is in sight though not yet in reach.”
Stella Kyriakides, Commissioner for Health and Food Safety, said: “Working together with unity, solidary and determination, we can soon start to see the beginning of the end of the pandemic. Now in particular, we need swift and coordinated action against the new variants of the virus. Vaccinations will still take time until they reach all Europeans and until then we must take immediate, coordinated and proactive steps together. Vaccinations must accelerate across the EU and testing and sequencing must be increased – this is show we can ensure that we leave this crisis behind us as soon as possible.”
Coronavirus response: EU support for regions to work together in innovative pilot projects
The Commission has announced the winners of a new EU-funded initiative for interregional partnerships in four areas: coronavirus-related innovative solutions, circular economy in health, sustainable and digital tourism, and hydrogen technologies in carbon–intensive regions. The aim of this new pilot action, which builds on the successful experience of a similar action on “interregional innovation projects” launched at the end of 2017, is to mobilise regional and national innovation actors to address the impact of coronavirus. This initiative also helps the recovery using the new Commission programmes through scaling up projects in new priority areas, such as health, tourism or hydrogen.
Commissioner for Cohesion and Reforms, Elisa Ferreira, said: “Interregional partnerships are proof that when we cooperate beyond borders, we are stronger as we come up with smart and useful solutions for all. This new pilot initiative supporting interregional innovative partnerships is especially important in the current coronavirus context, showing how much cohesion policy is committed to contribute to Europe’s prompt response and recovery.”
Following a Commission’s call for expression of interest launched in July 2020, four interregional partnerships were selected, with one or several coordinating regions in the lead:
- País Vasco (ES), together with three regions, will focus on the support to an emerging industry sector for prediction and prevention of the coronavirus pandemic;
- In the field of Circular Economy in Health, the RegioTex partnership on textile innovation involves 16 regions led by North Portugal (PT);
- In the field of Sustainable and Digital Tourism, the partnership coordinated by the Time Machine Organisation, an international cooperation network in technology, science and cultural heritage, involves five regions and Cyprus, led by Thüringen (DE);
- In order to enable the development of innovative solutions based on Hydrogen technologies in carbon–intensive regions with a broad geographical coverage, two partnerships will merge: the European Hydrogen Valleys partnership gathering 12 regions led by Aragon (ES), Auvergne Rhône Alpes (FR), Normandie (FR) and Northern Netherlands (NL), and the partnership led by Košice Region (SK) with four other regions.
These partnerships will benefit from the Commission experts’ support, providing, among others, advice on how to best combine EU funds to finance projects. In addition to this hands-on support from the Commission, each partnership can benefit from external advisory service of up to €100,000 for scale-up and commercialisation activities. The money comes from the European Regional Development Fund (ERDF).
The work with the partnerships will start in this month and will run for one year.This pilot further stimulates interregional cooperation, with the possibility for the partnerships to apply for support under the new programmes and the “Interregional Innovation Investment” instrument from 2021 onwards.
In recent years, the Commission has called on national and regional authorities to develop smart specialisation strategies aiming at more effective innovation policies and enhanced interregional cooperation in value chains across borders. To date, more than 180 regional smart specialisation strategies have been adopted. Their implementation is supported by €40 billion of EU Cohesion policy funds.
As part of a set of actions presented in 2017 by the Commission to take smart specialisation a step further, a pilot action on “Interregional innovation projects” sought to test new ways to encourage regions and cities to develop new value chains and scale up their good ideas in the EU single market. This pilot action, which involved nine partnerships in high-tech priority sectors, was completed in 2019 and showed significant potential to accelerate the investment readiness of interregional investment projects.
The lessons learned will be integrated in the new “Interregional Innovation Investment” instrument proposed in the framework of the post 2020 Cohesion Policy package.
The new pilot action has similar goals. Moreover, in the context of the crisis, it aims at finding solutions to the coronavirus challenges and accelerating the recovery through the commercialisation and scale-up of innovation investment.
Commission proposes to purchase up to 300 million additional doses of BioNTech-Pfizer vaccine
The European Commission today proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses.
This would enable the EU to purchase up to 600 million doses of this vaccine, which is already being used across the EU.
The additional doses will be delivered starting in the second quarter of 2021.
The EU has acquired a broad portfolio of vaccines with different technologies. It has secured up to 2.3 billion doses from the most promising vaccine candidates for Europe and its neighbourhood.
In addition to the BioNTech-Pfizer vaccine, a second vaccine, produced by Moderna, was authorised on 6 January 2021. Other vaccines are expected to be approved soon.
This vaccine portfolio would enable the EU not only to cover the needs of its whole population, but also to supply vaccines to neighbouring countries.
Can The Lessons of 2008 Spare Emerging Europe’s Financial Sector From The COVID-19 Cliff?
The more we know about the past, the better we can prepare for the future. The 2008 financial crisis provides...
COVID’s led to ‘massive’ income and productivity losses
Job losses or reduced working hours due to the impact of the COVID-19 pandemic cost the world the equivalent of...
Russia at Crossroads with Europe
The European politics has been hazy over the course of the last decade. Whether it highlights the shocking exit of...
Syria: 18 children killed since the start of the year
The brutal fighting in Syria continues to exact a terrible toll on children, with at least 18, including a one-year-old...
The strategic thinking behind the EU-China investment deal
Washington was understandably perplexed that a China-EU investment agreement was concluded a few weeks before the Biden administration, especially a ...
Deloitte Bolsters Cyber Threat Hunting Capabilities with Root9B Acquisition
Deloitte & Touche LLP announced today its acquisition of substantially all the assets of Root9B, LLC (R9B), a leading provider of...
100th Anniversary of the Turkish Constitution
Teşkilatı-Esasiye Law, the law provides for the establishment of the State of Turkey on January 20, 1921. This law also...
Defense3 days ago
Israel continues its air strikes against Syria after Biden’s inauguration: What’s next?
Europe2 days ago
Talking Turkey With Greece: Turkey and Israel’s Marriage of Convenience
Middle East3 days ago
When is usury usury? Turkish fatwa casts doubt on Erdogan’s religious soft power drive
Defense2 days ago
Pakistan Army’s Ranking improved
Economy2 days ago
Pandemic Recovery Creates a 50-50 Future
Energy News3 days ago
Solar power charges pandemic recovery for indigenous farmers in Viet Nam
Diplomacy2 days ago
India-made Covid vaccines open a new chapter in New Delhi’s continuing medical diplomacy
Americas2 days ago
The 4 groups of Senate Republicans that will decide Trump’s impeachment trial